Jessica Rose, Ph.D., a research fellow at the Institute for Pure and Applied Knowledge in Israel, has taken a deep-dive into the U.S. Vaccine Adverse Events Reporting System (VAERS), and in this interview she shares the details of what she’s finding.
• The U.S. Vaccine Adverse Event Reporting System (VAERS) is among the best adverse event data collection systems in the world, but it’s antiquated and difficult to use. Still, it’s a good way to detect safety signals that weren’t detected during premarket testing or clinical trials
• There are unmistakable, unprecedented safety signals in VAERS for the COVID shots. While the U.S. Food and Drug Administration and Centers for Disease Control and Prevention claim no deaths can be attributed to the COVID jabs, it’s impossible to discount 8,986 deaths in the U.S. territories alone, reported as of November 26, 2021
• The estimated underreporting factor for COVID jab injuries in VAERS is between 31 and 100, so the actual death toll in the U.S. could be anywhere from 278,500 to 898,600
• There’s a strong safety signal for female reproductive issues and for heart inflammation (myocarditis) in young men and boys. VAERS data show an inverse relationship between myocarditis and age, with youths being more frequently affected than older men
• VAERS data are being deleted without explanation. Each week, about 100 or so reports are routinely deleted, so there are now thousands of inexplicably missing reports
“Steve [Kirsch] and I are good friends. We’ve been working very closely on all of this stuff for a long time. His underreporting factor is 41. He estimated that based on a peer-reviewed publication that estimated anaphylaxis numbers, so he used anaphylaxis as a proxy for death.
What that means is that when you hear us say these numbers, you have to multiply them by 41, if you want to go with Steve’s estimate, or 31, in the case of mine. Mine is the most conservative estimate. I took Pfizer’s Phase 3 clinical trial data that they presented to the FDA.
There were over 18,000 participants in the drug group and the placebo groups, and there were a certain percentage of individuals in each arm that succumbed to a severe adverse event, which includes death, hospitalization, visit to the ER, a life threatening adverse event, disability or birth defect.
So, 0.7% of people in the drug arm succumbed to a severe adverse event according to their data. I used that rate, and multiplied it by the number of people who had been injected with one shot of Pfizer on a certain date, August 10, and that number becomes your expected number of people that would succumb to a severe adverse event based on their data.
So, you take that number and divide it by the number of reports of severe adverse events, and you get a multiplication factor, an underreporting factor. When you use that base dataset, the Pfizer Phase 3 clinical trial data, you get 31. Ronald Kostoff has also published a paper in Toxicology Reports, and his estimate is 100, I believe.
So, whenever you’re talking about the underreporting factor, I think you should talk about it in terms of a range, because each adverse event is going to have their own [underreporting factor] …
I think if people actually knew the reality of what was going on, they would decide very quickly, right now, never to go near these things. This isn’t hearsay. It’s not conjecture. The clinical trials are garbage, and there’s no safety data. I’m not just saying this — it’s very reflective in all of these adverse event data collection systems all over the world.
They’re all saying the same thing, the Yellow Card [system in the U.K.], the U.S. [VAERS], Australia’s [system9]. They’re all saying the same thing. As an example, myocarditis and young boys. You know, it’s not something that you can ignore. There’s a reason why this is happening. It’s because the [shots] are not safe.”